Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
Citations Over TimeTop 1% of 2015 papers
Abstract
Circulating tumour DNA analysis can be used to track tumour burden and analyse cancer genomes non-invasively but the extent to which it represents metastatic heterogeneity is unknown. Here we follow a patient with metastatic ER-positive and HER2-positive breast cancer receiving two lines of targeted therapy over 3 years. We characterize genomic architecture and infer clonal evolution in eight tumour biopsies and nine plasma samples collected over 1,193 days of clinical follow-up using exome and targeted amplicon sequencing. Mutation levels in the plasma samples reflect the clonal hierarchy inferred from sequencing of tumour biopsies. Serial changes in circulating levels of sub-clonal private mutations correlate with different treatment responses between metastatic sites. This comparison of biopsy and plasma samples in a single patient with metastatic breast cancer shows that circulating tumour DNA can allow real-time sampling of multifocal clonal evolution.
Related Papers
- → Integrating liquid biopsies into the management of cancer(2017)1,884 cited
- → Liquid biopsy: monitoring cancer-genetics in the blood(2013)1,829 cited
- → Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma(2019)51 cited
- → Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers(2017)48 cited